These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 4075595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J, Chaimovitz C, Abulfil A, Mostovlavsky M, Gazit D, Bab I.
    Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.
    Touam M, Martinez F, Lacour B, Bourdon R, Zingraff J, Di Giulio S, Drüeke T.
    Clin Nephrol; 1983 Jun; 19(6):295-8. PubMed ID: 6872366
    [Abstract] [Full Text] [Related]

  • 8. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    Swartz R, Dombrouski J, Burnatowska-Hledin M, Mayor G.
    Am J Kidney Dis; 1987 Mar; 9(3):217-23. PubMed ID: 3826071
    [Abstract] [Full Text] [Related]

  • 9. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH, Roodvoets AP, Van Groningen K.
    Neth J Med; 1985 Mar; 28(1):6-11. PubMed ID: 3974771
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 12. Aluminum bone disease. (A case study).
    Coleman S.
    J Nephrol Nurs; 1985 Feb; 2(3):125-6. PubMed ID: 3848476
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recognition and management of aluminum intoxication in children.
    Tsuru N, Williams JL, Chan JC.
    Int J Pediatr Nephrol; 1987 Feb; 8(3):177-86. PubMed ID: 3323095
    [Abstract] [Full Text] [Related]

  • 15. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M, Popławski A, Kaliszewski Z, Juzwiuk J.
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [Abstract] [Full Text] [Related]

  • 16. [Aluminum-induced osteomalacia in chronic hemodialysis].
    Smetana S, Popovtzer MM, Bar-Khayim Y.
    Harefuah; 1987 Jun 15; 112(12):595-7. PubMed ID: 3428727
    [No Abstract] [Full Text] [Related]

  • 17. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
    Charhon SA, Chavassieux P, Chapuy MC, Accominotti M, Traeger J, Meunier PJ.
    Presse Med; 1986 Jan 18; 15(2):55-9. PubMed ID: 2935857
    [Abstract] [Full Text] [Related]

  • 18. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 19. [Bone mineral content and treatment with deferoxamine in patients under chronic hemodialysis].
    Zanchetta JR, Bogado CE, Zuchini A, Firmat J.
    Medicina (B Aires); 1992 Jun 14; 52(2):184-5. PubMed ID: 1308914
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.